Ulrik Haagen Panton

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

Stuart J. McGurnaghan, Luke A. K. Blackbourn, Emina Mocevic et al. · Diabetic Medicine · 2018 · 90 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Costs of the <scp>COVID</scp>‐19 pandemic associated with obesity in Europe: A health‐care cost model

Sébastien Czernichow, Stephen C. Bain, Matthew Capehorn et al. · Clinical Obesity · 2021 · 37 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model

Stephen C. Bain, Sébastien Czernichow, Mette Bøgelund et al. · Current Medical Research and Opinion · 2020 · 33 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States

Emily Durden, Michael Liang, Robert Fowler et al. · Journal of Managed Care & Specialty Pharmacy · 2019 · 30 citations · Full text

Medicine, Pharmacotherapy, Self-management Support +14

Effective diabetes complication management is a step toward a carbon-efficient planet: an economic modeling study

Richard Fordham, Ketan Dhatariya, Rachel Stancliffe et al. · BMJ Open Diabetes Research & Care · 2020 · 19 citations · Full text

Pharmacy, Chronic Disease Control, Pharmacoeconomics +17